Magnesium Administration For COPD Exacerbation: A Systematic Review and Meta-analysis

Journal Title: The Journal of Medicine, Law & Public Health (JMLPH) - Year 2021, Vol 1, Issue 2

Abstract

BACKGROUND The role of magnesium in patients with acute chronic obstructive pulmonary disease (COPD) exacerbation remains to be determined. AIM We aim to explore the effect of magnesium on COPD exacerbation, as well as its impact on pulmonary function tests and on hospital admissions for acute exacerbation in the emergency department. METHODS This is a systematic review and meta-analysis that included a search of the keywords "magnesium" and "COPD" on PubMed, Google Scholar, Cochrane databases, and Gray literature (ClinicalTrials.gov and World Health Organization International Clinical Trials Registry Platform) from 1963 to May 2021. RESULTS The use of IV magnesium reduced the risk ratio for admission RR= 0.85 (95% CI 0.62 to 1.17). The combined risk ratio for admission increased to 0.95 when we added nebulised magnesium sulphate (95% CI 0.85 to 1.07), p>0.05. The mean score for improvement after IV magnesium was higher (M=16.75, SD=5.11) than the mean score before its administration (M=8.74, SD=8.85), t(4)=-2.57, p=0.031. Thus, the use of IV magnesium sulphate results in a 91.64% improvement in the pulmonary function test. CONCLUSION IV magnesium sulphate improves the pulmonary function test of patients with acute COPD exacerbation in the ED, and possibly reduces the admission rate.

Authors and Affiliations

Hala Alzaid, Fay Aldossari, Sharafaldeen Bin Nafisah

Keywords

Related Articles

A critical case commentary on Avon and Wiltshire Mental Health Partnership and North Bristol NHS Trust v WA and DT: Did the judge reach a fair and just decision regarding the capacity and best interest of the person?

Avon and Wiltshire Mental Health Partnership and North Bristol NHS Trust v WA and DT [2020] EWCOP, [2020] 7 WLUK 271: This case critically evaluates the findings on WA’s capacity assessment and best interest decision mad...

Lactation Ketoacidosis in a COVID- 19 patient: A Case Report

Lactation ketoacidosis is an uncommon cause of high anion gap metabolic acidosis affecting breastfeeding women due to increased metabolic demands, reduction in carbohydrate intake, and acute illness. Meanwhile, recent li...

Evaluating the Precision of ChatGPT Artificial Intelligence in Emergency Differential Diagnosis

Introduction: artificial intelligence (AI) is the study and development of intelligent machines that can carry out tasks that would typically require human intelligence. AI seeks to give machines the ability to think, pr...

Acute Myocardial Infarction Complicated by Death in a Young Medically Free Female: A Case Report

Cardiovascular disease, and particularly myocardial infarction (MI), is the leading cause of disability and death in women worldwide. Young females with MI have previously been disregarded from inclusion in mass epidemio...

Clinical Research in Saudi Arabia: Trainee Knowledge and Attitude

Background Clinical research is an integral part of medical and surgical residency programmes, as well as medical school. Aim This study aimed to investigate attitudes toward, the experience of, and perceived barriers...

Download PDF file
  • EP ID EP732198
  • DOI https://doi.org/10.52609/jmlph.v1i3.22
  • Views 54
  • Downloads 0

How To Cite

Hala Alzaid, Fay Aldossari, Sharafaldeen Bin Nafisah (2021). Magnesium Administration For COPD Exacerbation: A Systematic Review and Meta-analysis. The Journal of Medicine, Law & Public Health (JMLPH), 1(2), -. https://europub.co.uk/articles/-A-732198